Sharps Technology, Inc., a medical device and pharmaceutical packaging company, provides smart-safety syringe products to the healthcare industry. Its product lines focus on providing waste capabilities that incorporate syringe technologies. The company, through a digital asset treasury strategy, focuses on accumulatin…
An institutional-grade, numbers-driven thesis on STSS — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of July 4, 2026, TradersQuant's model rates Sharps Technology, Inc. (STSS) 49/100 with a 12-month base-case forecast of $0.63 — -47.9% versus the current price of $1.21. Sharps Technology, Inc. trades at $1.21 in the Healthcare sector, with a market capitalisation of $51.2M. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month TradersQuant model price target for STSS is $0.63, implying -47.9% versus the current price. The model's 12-month scenario range runs from $0.24 (bear) to $1.14 (bull), with a base case of $0.63.
On the fundamentals, Sharps Technology shows a P/E of 1.4, trailing revenue of $204120, revenue growth of +0.0% YoY. This page also tracks STSS's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
STSS currently carries a TradersQuant composite score of 49/100, which we read as a cautious signal. The Wall-Street analyst consensus is "Buy". Our 12-month price target of $0.63 implies -47.9% from $1.21. This is research, not financial advice — always combine it with your own judgement.
The TradersQuant 12-month model price target for STSS is $0.63, about -47.9% versus the latest price of $1.21. Consensus is based on 1 analysts.
TradersQuant's 12-month model forecast for STSS is a base case of $0.63, ranging from $0.24 (bear) to $1.14 (bull), an expected return of -48.3%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for STSS over the next 12 months is $0.63 in the base case (bear $0.24, bull $1.14), versus today's price of $1.21. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for STSS — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates STSS's fair value at $1.50, implying +24.3% of expected upside versus the current price.
Sharps Technology does not currently pay a dividend.
Data and model outputs are for research only and are not financial advice. Figures update continuously.
